Online inquiry

IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25048MR)

This product GTTS-WK25048MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL6IP4 protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001002251.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51329
UniProt ID Q66PJ3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25048MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK22567MR IVTScrip™ mRNA-Human ARF5, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARF5
GTTS-WK24817MR IVTScrip™ mRNA-Human ASMA, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ASMA
GTTS-WK11892MR IVTScrip™ mRNA-Human ADAM19, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADAM19
GTTS-WK15812MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK9720MR IVTScrip™ mRNA-Human ACD, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACD
GTTS-WK16103MR IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD17
GTTS-WK13060MR IVTScrip™ mRNA-Human ACTG2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACTG2
GTTS-WK25271MR IVTScrip™ mRNA-Human ARFGAP3, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARFGAP3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →